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Abstract  
 
Introduction: Current MRI sequences are limited in identifying brain areas at risk for high 
grade glioma recurrence. We employed intraoperative 3-Tesla functional MRI to assess 
cerebrovascular reactivity (CVR) after high-grade glioma resection and analyzed regional 
CVR responses in areas of tumor recurrence on clinical follow-up imaging.  
Methods: Five subjects with high-grade glioma that underwent an intraoperative Blood 
Oxygen-Level Dependent (BOLD) MRI CVR examination and had a clinical follow-up of at 
least 18 months were selected from a prospective database. For this study, location of tumor 
recurrence was spatially matched to the intraoperative imaging to assess CVR response in that 
particular area. CVR is defined as the percent BOLD signal change during repeated cycles of 
apnea.  
Results: Of the 5 subjects (mean age 44, 2 females), 4 were diagnosed with a WHO grade III 
and 1 subject with a WHO grade IV glioma. Three subjects exhibited a tumor recurrence on 
clinical follow-up MRI (mean: 15 months). BOLD CVR measured in the spatially matched 
area of tumor recurrence was on average 64% increased (range -29% to 123%) as compared 
to whole brain CVR response, 1.50±0.81 versus 1.09±0.37 respectively. 
Conclusion: For this first analysis in a small cohort, we found altered intraoperative CVR in 
brain areas exhibiting high grade glioma recurrence on clinical follow-up imaging.  
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1. Introduction 
Currently, the best available neuroimaging biomarker for identifying high grade gliomas is 
conventional contrast-enhanced magnetic resonance imaging (CE-MRI).[1] The ability of 
obtaining this sequence with intraoperative MRI further enhances resection control by 
providing a timely evaluation of tumor residual that can be removed additionally. [2-4]  CE-
MRI sequences, however, are inherently limited to exactly identify tumor borders due to 
heterogeneous tumor enhancement and cannot assess functional parameters such as tumor 
molecular biology.  Therefore, O-(2-[18F]fluoroethyl)-L tyrosine Positron Emission 
Tomography,  (FET-PET) may potentially better depict high grade glioma tissue, but lower 
spatial resolution and limited clinical availability are remaining challenges.[5]   
 
Cerebrovascular reactivity (CVR) is a functional parameter that can be assessed with MRI by 
obtaining Blood Oxygen-Level Dependent (BOLD) volumes. CVR is determined as the 
BOLD signal response due to deoxyhemoglobin washout related to carbon dioxide (CO2) 
changes as the vasoactive stimulus,[6]and can be measured on high spatial resolution covering 
the entire brain.  Using this concept, Hsu et al. [7] have demonstrated that BOLD MRI 
generates CVR patterns to better distinguish normal brain tissue from glioma tissue. Bashat et 
al.[8]used BOLD CVR to assess the effect of anti-angiogenesis tumor therapies in subjects 
with intracranial high-grade gliomas, and found that such an assessment can complement 
existing MR techniques for better detection and follow-up of angiogenic changes.  
 
The use of intraoperative BOLD CVR for intracranial tumors has not been reported thus far. 
We hypothesized that intraoperative BOLD CVR is altered in perifocal non-contrast 
enhancing tissue prone to future tumor recurrence. For this initial study we analyzed five 
consecutive subjects from an ongoing prospective intraoperative BOLD CVR study that 
underwent high-grade glioma resection. All subjects were postoperatively followed with 
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clinical CE-MRI imaging. Three subjects exhibited a tumor recurrence within 2 years of 
follow-up. The area of tumor recurrence on follow-up CE-MRI was spatially matched with 
the intraoperative BOLD CVR data to assess CVR response in that particular area.  
 
 
2. Materials & Methods 
2.1 Subject selection  
This study was approved by the cantonal ethics board of the Canton of Zurich, Switzerland 
(KEK-ZH-Nr. 2012-0427). In October 2013 we have started an ongoing prospective study of 
intraoperative BOLD MRI CVR in subjects undergoing a cerebral glioma resection to assess 
regional CVR patterns.  For this analysis, we selected subjects from this prospective database 
with high-grade glioma, defined as histopathological type III or IV according to WHO 
criteria, and a minimum of 18 months follow-up after tumor resection. Five consecutive 
subjects were found eligible.  
The study protocol consisted of an additional BOLD MRI sequence with 3 cycles of apnea 
(i.e. CO2 changes) during a scheduled intraoperative MRI examination following tumor 
resection. All subjects gave signed consent for study participation preoperatively. Subjects 
that were not able to sign consent were excluded as well as subjects with any predisposing 
cardio-pulmonary condition requiring special anesthetic care during surgery.  
 
2.2 Intraoperative BOLD MRI imaging protocol 
Mechanically ventilated subjects were scanned on a 3-Tesla Siemens Skyra VD13 (Siemens, 
Erlangen, Germany). Images were obtained using a customized intraoperative 8 channels head 
coil (NORAS MRI products, Hochberg, Germany), incorporated with a MRI compatible 
surgical four-point head-fixation system in which the subjects` head was placed at surgery. 
Whole brain BOLD volumes were collected with an axial 7.20 minute 2D echo planar 
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imaging (EPI) BOLD sequence with voxel size: 3×3×3 mm3, acquisition of matrix 64x64, 35 
slices with ascending interleaved acquisition, slice gap 0.3 mm, GRAPPA factor 2 with 32 
ref. lines, adaptive Coil Combination, Auto Coil Selection, TR/TE 2000/30 ms, flip angle 85°, 
bandwidth 2368 Hz/Px, 220 volumes, field of view 192mm x 192mm. For co-registration of 
the functional sequence, skull stripping and overlay purposes, the anatomical T1-weighted- 
MPRAGE sequence (Voxel size: 0.5×0.5×0.9 mm, Field of View read 240 mm, Slice 
thickness 0.90 mm, TR 1900.0 ms, TE 2.60 ms, Flip angle 9 deg,  Base resolution 256, Phase 
resolution 100 %, Interpolation to 512x512 ) from the clinical protocol was used. The field of 
view from the BOLD image acquisition was copied to the T1-weighted image for better early 
realignment of both images.  
 
2.3 CO2 stimulus during BOLD acquisitions 
BOLD signal changes were made by three cycles of apnea to induce hypercapnia (ie. higher 
CO2 levels) under direct neuro-anesthetic monitoring. During the first 88 second, regular 
mechanically ventilated breathing was continued to provide a baseline, after which a 44 
second apnea - breath hold - period was initiated by halting the ventilator. After apnea the 
subject was manually hyperventilated to swiftly return to baseline CO2 value. In total, 3 
identical series of 44 seconds apnea were done during the BOLD sequence with an interval 
baseline period of 88 seconds. A 44 second apnea paradigm is expected to provide a robust 
CO2 change within physiological range. [9] Furthermore, following standard clinical 
management during intraoperative MRI examinations at our institution, subjects were 
continuously monitored by our neuro-anesthetic team.  
 
2.4 Data analysis 
The images were preprocessed using Statistical Parameter Mapping software (SPM 12, 
Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College 
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London; http://www.fil.ion.ucl.ac.uk/spm/). A mean BOLD volume was calculated and the 
T1-weighted image was linearly registered to this volume. Automated segmentation of the 
T1-weighted image generated grey and white matter, cerebrospinal fluid, skull and skin 
probability maps.  The BOLD images were smoothed with an 8x8x8-mm full width half 
maximum Gaussian kernel. Due to the four point head fixation, we assumed minimal head 
motion could occur during the MRI acquisition. Therefore, correcting for head-motion in 
realignment was not considered necessary. Temporal smoothing included a low pass filter of 
0.125Hz and robust Loess smoothing (dynamic local regression of 6%).  
 
2.5 Cerebrovascular reactivity maps 
MRI volumes were analyzed using in-house scripts written in MATLAB2013 (The 
MathWorks, Inc, Natick, United States; http://www.mathworks.com/). MR time-courses were 
detrended by fitting a linear series to the data. A Sine wave was created with a separate 
frequency for the apnea period and ventilation period. To increase Coherence, we calculated 
the maximum Pearson product-moment correlation and shifted the Sine wave to its best fit 
with the BOLD data on a voxel-wise base. After applying a combined grey and white matter 
mask with a threshold of 0.9, CVR, defined as the percent BOLD change, was then calculated 
using a voxel-wise linear regression of BOLD time series versus the Sine wave with least 
square fitting.  
The resected tumor area matched the signal intensity of CSF and was automatically not 
included in the calculations.  Hemispheres were manually segmented in left and right 
hemisphere and CVR was calculated separately for both. CVR maps were color-coded and 
overlayed on the T1-weighted image (Figure 1).  
 
2.6 Extended analysis  
2.6.1 Intraoperative residual tumor 
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An experienced staff neuroradiologist (A.P.) determined the presence of residual tumor on 
intraoperative clinical MRI. When present, we extracted the T1-CE and T2 fluid-inversion 
attenuated recovery (FLAIR) images to perform an automated delineation analysis. In 
summary, first, to align the images a linear registration was done using the T1-weighted 
image as the reference. Both T1-weighted images were normalized to their mean and standard 
deviation on a voxel-wise base which has been shown to improve contrast to noise in the 
images. [10] Thereafter, the normalized T1-CE was subtracted from the normalized T1-
weighted to create the subtraction map (Figure 2).  
To determine pathological voxels, the FLAIR image was aligned with the subtraction image 
and normalized in a similar manner as both the T1-weighted images. After evaluation of these 
normalized maps, it was decided to threshold the FLAIR image at a fixed value of 5 to 
generate a binary mask only including voxels with FLAIR signal hyperintensities. To finally 
delineate the residual tumor, the binary FLAIR mask and a combined grey and white matter 
mask (Threshold 0.9) were placed over the normalized subtraction map (Figure 1C). This 
allowed for exclusion of physiological contrast-enhanced regions (large arteries, meninges) as 
well as exclusion of voxels outside of the brain. Voxels within the delineated tumor map with 
a positive Δ signal increase (voxels increasing in intensity after administration of contrast) 
were included for further evaluation.  
 
2.6.2 Tumor recurrence  
Based on standard clinical CE-MR imaging during follow-up, the presence of 
tumor recurrence was evaluated by an experienced staff neuroradiologist. In two subjects, an 
additional histopathological analysis of tumor recurrence was possible due to second surgical 
tumor resection. Similar to the tumor residual, a tumor mask of the tumor recurrence was 
created by automated delineation analysis.  
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With the use of the T1-weighted volume, the tumor mask was coregistered to the 
intraoperative volume (Figure 1C). Thereafter, the tumor mask was placed over the CVR map 
to locate regions of recurrence on the intraoperative CVR map. Subsequently CVR in those 
regions was calculated.  
 
3. Results 
3.1 Subjects 
Of the five eligible subjects (mean age 44, range 38-51, 2 females), 1 subject had a WHO 
grade IV and 4 a WHO grade III cerebral glioma (Table 1). All gliomas were located in the 
left frontal region. The mean postoperative follow-up was 24 months ± 2.0. Three subjects 
exhibited a tumor recurrence on follow-up CE-MRI imaging at an average of 15 months 
(range 11-18).  
 
3.2 Cerebrovascular reactivity findings 
Whole brain CVR, and CVR for both hemispheres separately are presented in Table 2. Mean 
CVR in the ipsilateral hemisphere vs. the contralateral hemisphere did not differ significantly 
(p=0.4).  
 
3.2.1 Residual tumor on intraoperative CE-MRI  
Three subjects had a residual tumor on intraoperative CE-MRI which was subsequently 
further resected during the same surgery. CVR in the area of residual tumor was 1.87±0.53 on 
average as compared to whole brain CVR 1.09 ±0.37, a 122% mean CVR increase (Table 2).  
 
3.2.2 Tumor recurrence on follow-up clinical CE-MRI 
Tumor recurrence was found in three subjects on CE-MRI. The area of tumor recurrence was 
spatially matched to the intraoperatively acquired BOLD CVR data. CVR in the area of tumor 
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recurrence was 1.50 ±0.81.This was considerably different from whole brain CVR, 1.09 
±0.37, an overall 64% CVR increase (Table 2).  
The tumor recurrence in subject 1 (Table 2) was decided not to be resected surgically but 
treated with a second round of chemotherapy in combination with Bevacizumab. The area of 
tumor recurrence, which was spatially matched to the intraoperative BOLD-CVR map (Figure 
1), exhibited a 29 % CVR decrease as compared to whole brain CVR, 0.90 vs 0.64 
respectively. The other two subjects underwent a second surgical tumor resection with 
histopathological analysis showing a recurrence of an anaplastic astrocytoma WHO grade III 
and glioblastoma WHO grade IV (subject 3 & 4 respectively; Table 2). For subject 3, no 
contrast enhancement was seen on T1, but diagnosis of recurrence was made based on FLAIR 
T2 imaging. Interestingly for this subject, after subtraction of the non-contrast enhanced T1-
weighted from the CE-T1-weighted images (see methods), a contrast enhanced tumor area 
was found matching the FLAIR enhancement (Figure 2). The area of tumor recurrence for this 
subject was 123% increased as compared to whole brain CVR (1.01 vs. 2.26).  CVR values 
for subject 4 were 0.85 vs. 1.60; a 99% CVR increase (whole brain vs. recurrence). 
 
4. Discussion 
Our preliminary findings in a small cohort (n= 5) demonstrate that intraoperative BOLD MRI 
provides feasible CVR measurements in subjects undergoing resection of high-grade cerebral 
glioma. Of the five subjects included, three developed a tumor recurrence on follow-up 
imaging (average duration from surgery to recurrence was 15 months). The area of tumor 
recurrence at follow-up was spatially matched onto the intraoperative BOLD CVR data 
acquired at the first surgery (see methods section). In this area of tumor recurrence, CVR was 
1.50 ±0.81 vs.1.09 ±0.37 for whole brain, corresponding to a mean CVR increase of 64%. No 
significant CVR differences were found between the ipsi- and contralateral hemispheres, 
indicating a marked regional CVR change in the area of tumor recurrence.  
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4.1 Significance of CVR in high-grade glioma  
MR-based imaging modalities assessing cerebrovascular autoregulation and CVR have not 
been explored widely for high-grade cerebral glioma. This may be related to heterogeneity of 
the disease, posing methodological challenges on acquiring useful functional imaging 
information. Preliminary studies on human subjects suggest that BOLD CVR may be a 
potential tool to distinguish between normal brain tissue and cerebral glioma. This may hold 
great promise since one of the largest remaining challenges of current conventional MRI 
techniques is better depiction of tumor margins. Moreover, a BOLD-CVR examination may 
even differentiate between low-grade versus high-grade gliomas. For instance, in a small 
series reported by Hsu et al.[7] steal phenomenon was found in high-grade gliomas, an 
observation not made in low-grade gliomas. The authors hypothesized that under hypercapnic 
stress, blood from a region of the tumor in which the vessels do not dilate due to abnormal 
angiogenesis is redistributed to a responsive tumor region and surrounding normal tissue, 
causing a focal steal phenomenon with decrease of tumor perfusion.  The steal phenomenon is 
expected to be exaggerated in a tumor region where cellularity is high (greater oxygen 
demand) and neovascularization is marked (absent CO2-induced vasodilatation), resulting in 
reduced BOLD signal. Bashat et al.[8] used BOLD CVR to assess the effect of anti-
angiogenesis tumor therapies in patients with cerebral high-grade glioma. Termed 
hemodynamic response imaging, the authors conclude that such an assessment can 
complement existing MR techniques for better detection and follow-up of angiogenetic 
activity.  
Animal studies have elaborated on the same findings. For instance Laufer et al.[11]assessed 
the hemodynamic response in a rat model with glioblastoma to verify its use in gauging effect 
of anti-angiogenesis therapy. Jerome et al.[12] utilized the 9L rat glioma model mimicking an 
aggressive intracranial high-grade glioma, to determine that BOLD CVR measures can 
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differentiate between core and rim zone tumor tissue. This may have potential use for 
differentiating the heterogeneous nature of high-grade gliomas on imaging.  
 
Another potential future application is the combined assessment of BOLD CVR in relation to 
visual, speech or sensorimotor task-based fMRI in brain eloquent areas. Currently, pre-
surgical task-based fMRI assists the neurosurgeon in identifying proximity of brain eloquent 
areas in patients with brain gliomas. A significant limitation of task-based fMRI, however, is 
false negative activation, termed neurovascular uncoupling.[13, 14] Here, the neurons are 
indeed signaling (ie. the subject performs a task, such as fingertapping), resulting in a BOLD 
signal change. When impaired CVR is present in these areas (something that cannot be 
assessed with conventional task-based BOLD fMRI) the BOLD signal change does not follow 
the expected signal increase, and may even be paradoxically decreased. Standard thresholding 
applied to task-based fMRI may therefore exclude such viable brain tissue, i.e. false negative 
activation, which may result in undesirable surgical resection and therefore irreversible 
neurological deficits. For such patients a supplementary BOLD-CVR examination may 
differentiate whether impaired CVR is present in brain eloquent areas, where neuronal 
viability can then be verified with for instance intraoperative direct electro-cortical 
stimulation mapping.   
 
We have developed a practical intraoperative BOLD-MRI + CO2 protocol that generates 
feasible regional and whole brain CVR measurements. The resulting BOLD CVR map was 
used as a functional overlay on the automatically segmented tumor recurrence masks as 
described in the methods section. Our CVR findings were quite heterogeneous, which may be 
indicative of heterogeneity of disease. The intraoperative tumor residual showed a trend 
towards increased CVR (mean CVR increase of 122%). Overall the intraoperative regional 
CVR in the areas of tumor recurrence was 64% higher as compared to whole brain CVR.  
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However there was heterogeneity in the results. One subject exhibited a CVR decrease of -
29%. This CVR decrease could represent underlying steal phenomenon in occult tumor tissue. 
This may be the result of increased angiogenesis resulting in abnormal vessels with failing 
autoregulation as has also been hypothesized by Hsu et al.[7] The marked increased CVR 
found in the other two subjects seems in contradiction with the previous theory of steal 
phenomenon and mandates a different explanation. Such an increase may be representative of 
a latent state of controlled hypervascularization due to underlying high metabolic activity, i.e. 
elevated oxygen demand –and increased cerebral blood flow. Here, we have to assume that 
tumor cells may be active in this tissue, however, not yet in an uncontrolled manner (i.e. no 
contrast enhancement and no steal phenomenon). Since there is no contrast enhancement, 
such a state may mimic a situation similar to a lower grade tumor stage before developing into 
more malignant. In their paper, Hsu et al.[7]  directly hinted to such a possibility by reporting 
that steal phenomenon was not found in subjects with low grade glioma. Another explanation 
may be that after tumor resection a state of local hyperreactivity occurs, since the source of 
high blood flow demand (the tumor mass) has been taken away and the surrounding blood 
vessels have to adapt to less blood flow demand. Clearly these hypotheses remain purely 
speculative.  
 
4.2 Limitations & future considerations 
These are preliminary findings and have to be interpreted with caution. First of all, our subject 
sample is small, therefore, limiting interpretation. At best we can report a trend of CVR 
increase in areas of tumor residual and recurrence. Nevertheless, with improved post-
processing analyses and automated determination of tumor area we were able to derive a 
robust global and regional CVR assessment.  
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Regarding the subject sample size, these datasets were obtained from an ongoing prospective 
study of intraoperative BOLD MRI CVR measurements in subjects undergoing an intracranial 
glioma resection to assess regional CVR patterns. Since we commenced this study in 2013, 
we only found 5 subjects eligible. Although a small number of subjects, the substantial CVR 
differences in areas of tumor recurrence provide encouraging results that deserve to be 
reported as preliminary results. We continue to study BOLD CVR as potential prospective 
imaging biomarkers for high grade glioma recurrence.    
Future considerations are ongoing subject enrollment, longer follow up and further 
standardization of the BOLD CVR technique to obtain quantitative data.
6
 Improvements of 
BOLD CVR methodologies have been proposed[13, 15] and may increase sensitivity and 
quantification of (regional) CVR measurements in subjects with high-grade cerebral glioma. 
Also, a preoperative BOLD CVR assessment may further our understanding of CVR response 
in high grade glioma tissue and may allow for a better comparison of regional CVR response 
in areas of tumor recurrence.  
 
5. Conclusions 
For this first analysis, we explored the application of intraoperative BOLD MRI CVR in a 
small series of subjects undergoing high grade glioma resection. The results demonstrate 
altered intraoperative CVR in brain areas of future tumor recurrence. 
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Figure legends 
 
Figure 1: Tumor recurrence, tumor mask & cerebrovascular reactivity map 
 
Caption Figure 1: Images presented in coronal orientation demonstrating the tumor cavity on 
the left frontal basis (1A, green arrows) with a clear demarcated contrast enhancing tumor 
recurrence on clinical follow-up imaging (1B, yellow arrow). The area of tumor recurrence 
was masked using the automated T1 tumor delineation method as described in the methods 
section, creating a tumor mask (1C, green) for which CVR was measured and compared to 
whole brain CVR (1D). Here CVR is color-coded, ranging from red (normal CVR)-yellow-
green-blue (severely impaired CVR) and projected on the T1-weighted anatomical 
intraoperative volume as a functional overlay. 
 
Figure 2: Automated T1-weighted tumor subtraction mask 
Caption Figure 2: Illustrative example of the automated T1-weighted tumor subtraction mask. 
Images are presented in coronal orientation. The mask was created by subtracting the CE-T1-
weighted image from the noncontrast T1-weighted image (methods). Interestingly, although 
the tumor (a WHO grade III anaplastic astrocytoma) did not exhibit contrast enhancement on 
the CE-T1-weighted volume (2A versus 2B, yellow arrows), the T1 subtraction map did 
clearly demarcate tumor recurrence (2C) spatially matching the area of hyperintensity on T2-
FLAIR imaging (2D). 
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Table 1: Subject demographics, tumor characteristics & follow-up 
Subject Age Sex Histology WHO Tumor 
location 
Tumor 
recurrence 
Time after 
surgery (m) 
total follow-up 
(m) 
1 38 M anaplastic 
astrocytoma 
III left frontal (+) 17 25 
2 41 F anaplastic 
oligoastrocytoma 
III left frontal (-)  24 
3 43 M anaplastic 
oligoastrocytoma 
III left frontal (+) 18 25 
4 51 M glioblastoma 
recurrence 
IV left frontal (+) 11 26 
5 46 F Anaplastic 
astrocytoma 
III left frontal (-)  21 
 
*Abbreviations: m = months 
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Table 2: Cerebrovascular reactivity findings 
 
 
* CVR is defined as the percentage BOLD signal change 
** The area of future tumor recurrence was projected retrograde on the intraoperative 
volume to determine intraoperative CVR for that area (methods)  
 
 
  Cerebrovascular reactivity (CVR)* 
Subject 
Whole 
brain 
Ipsilateral 
hemisphere 
Contralateral 
hemisphere 
Residual 
tumor 
% alteration 
from whole 
brain CVR 
Future 
tumor 
recurrence**  
% alteration from 
whole brain CVR 
1 0.90 0.83 0.94     0.64 -29% 
2 0.95 1.02 0.89 1.27 33%   
3 1.01 1.24 0.8 2.28 124% 2.26 123% 
4 0.85 1.01 0.69 2.06 208% 1.60 99% 
5 1.77 1.62 1.83         
Mean (±SD) 1.09 (0.37) 1.14 (0.30) 1.03 (0.46) 1.87 (0.53) 122% 1.5 (0.81) 64% 
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Figure legends 
 
 
Figure 1: Tumor recurrence, tumor mask & cerebrovascular reactivity map 
 
Caption Figure 1: Images presented in coronal orientation demonstrating the tumor cavity on 
the left frontal basis (1A, green arrows) with a clear demarcated contrast enhancing tumor 
recurrence on clinical follow-up imaging (1B, yellow arrow). The area of tumor recurrence 
was masked using the automated T1 tumor delineation method as described in the methods 
section, creating a tumor mask (1C, green) for which CVR was measured and compared to 
whole brain CVR (1D). Here CVR is color-coded, ranging from red (normal CVR)-yellow-
green-blue (severely impaired CVR) and projected on the T1-weighted anatomical 
intraoperative volume as a functional overlay. 
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Figure 2: Automated T1-weighted tumor subtraction mask 
 
Caption Figure 2: Illustrative example of the automated T1-weighted tumor subtraction mask. 
Images are presented in coronal orientation. The mask was created by subtracting the CE-T1-
weighted image from the noncontrast T1-weighted image (methods). Interestingly, although 
the tumor (a WHO grade III anaplastic astrocytoma) did not exhibit contrast enhancement on 
the CE-T1-weighted volume (2A versus 2B, yellow arrows), the T1 subtraction map did 
clearly demarcate tumor recurrence (2C) spatially matching the area of hyperintensity on T2-
FLAIR imaging (2D). 
 
 


